For instance, dual targeting of uPAR and PAI-1 has been proposed to disrupt the uPA-uPAR-PAI-1 axis more effectively, thereby inhibiting tumor progression and metastasis [93,175]. This evidence concerns the gene SERPINE1 and neoplasm.